The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Imigran 20 mg Nasal Spray, Solution



PCO Manufacturing Ltd.PPA0465/070/005

Main Information

Trade NameImigran 20 mg Nasal Spray, Solution
Active SubstancesSumatriptan
Dosage FormNasal spray, solution
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/070/005

Group Information

ATC CodeN02CC01 sumatriptan

Status

License statusAuthorised
Licence Issued23/02/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back